Evidence map›Paper›PMID 24448790›Full record

ArticleJournal of Alzheimer's disease : JAD2014

Caffeoylquinic acids in Centella asiatica protect against amyloid-β toxicity.

Nora E Gray, Jeff Morré, Jeremiah Kelley, Claudia S Maier, Jan F Stevens, Joseph F Quinn, Amala Soumyanath

Erratum issuedAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in aging · 2024
    Article
  11. Journal of Alzheimer's disease reports · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Characteristics of Phenolic Compounds inMolecules (Basel, Switzerland) · 2023
    Article
  16. Article
  17. A Comprehensive Review ofAntioxidants (Basel, Switzerland) · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nora E GrayDepartment of Neurology, Oregon Health and Science University, Portland, OR, USA.
Jeff MorréDepartment of Chemistry, Oregon State University, Corvallis, OR, USA.
Jeremiah KelleyDepartment of Chemistry, Oregon State University, Corvallis, OR, USA.
Claudia S MaierDepartment of Chemistry, Oregon State University, Corvallis, OR, USA.
Jan F StevensDepartment of Pharmaceutical Sciences and the Linus Pauling Institute, Oregon State University, Corvallis, OR, USA.
Joseph F QuinnDepartment of Neurology, Oregon Health and Science University, Portland, OR, USA Department of Neurology and Parkinson's Disease Research Education and Clinical Care Center (PADRECC), Portland Veterans Affairs Medical Center, Portland, OR, USA.
Amala SoumyanathDepartment of Neurology, Oregon Health and Science University, Portland, OR, USA.
Oregon State University · USOregon Health & Science University · US

Funding

Outreach, Recruitment and Education CoreP30AG008017 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WOLTJER, RANDALL L · 1990 to 2019
$27.7M
Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
CAM Research Training in Neuroscience &StressT32AT002688 · NCCIH · OREGON HEALTH & SCIENCE UNIVERSITY · PI OKEN, BARRY S, SOUMYANATH, AMALA · 2005 to 2025
$7.2M
Triple Quadrupole/Linear Ion Trap LC-MS/MS for LPIS10RR027878 · NCRR · OREGON STATE UNIVERSITY · PI STEVENS, JAN FREDERIK · 2010 to 2010
$484k
NCCIH NIH HHS AT002688NCCIH NIH HHS T32 AT002688NCRR NIH HHS S10 RR027878NCRR NIH HHS S10RR027878NIA NIH HHS 3P30 AG000817 24 S1NIA NIH HHS 5 P30 AG008017 24NIA NIH HHS P30 AG008017NIEHS NIH HHS P30 ES000210NIEHS NIH HHS P30ES000210
6 · The paper itself

Abstract

The accumulation of amyloid-β (Aβ) is a hallmark of Alzheimer's disease and is known to result in neurotoxicity both in vivo and in vitro. We previously demonstrated that treatment with the water extract of Centella asiatica (CAW) improves learning and memory deficits in Tg2576 mice, an animal model of Aβ accumulation. However the active compounds in CAW remain unknown. Here we used two in vitro models of Aβ toxicity to confirm this neuroprotective effect and identify several active constituents of the CAW extract. CAW reduced Aβ-induced cell death and attenuated Aβ-induced changes in tau expression and phosphorylation in both the MC65 and SH-SY5Y neuroblastoma cell lines. We confirmed and quantified the presence of several mono- and dicaffeoylquinic acids (CQAs) in CAW using chromatographic separation coupled to mass spectrometry and ultraviolet spectroscopy. Multiple dicaffeoylquinic acids showed efficacy in protecting MC65 cells against Aβ-induced cytotoxicity. Isochlorogenic acid A and 1,5-dicaffeoylquinic acid were found to be the most abundant CQAs in CAW, and the most active in protecting MC65 cells from Aβ-induced cell death. Both compounds showed neuroprotective activity in MC65 and SH-SY5Y cells at concentrations comparable to their levels in CAW. Each compound not only mitigated Aβ-induced cell death, but was able to attenuate Aβ-induced alterations in tau expression and phosphorylation in both cell lines, as seen with CAW. These data suggest that CQAs are active neuroprotective components in CAW, and therefore are important markers for future studies on CAW standardization, bioavailability, and dosing.

Indexed as

Amyloid beta-PeptidesCell DeathCell Line, TransformedCentellaChlorogenic AcidChromatography, High Pressure LiquidDose-Response Relationship, DrugGene Expression Regulation, EnzymologicHumansNeuroblastomaNeuroprotective AgentsQuinic Acidtau ProteinsAmyloid beta-Peptidescaffeoylquinic acidChlorogenic Acidisochlorogenic acidNeuroprotective AgentsQuinic Acidtau ProteinsAmyloid-β toxicitycaffeoylquinic acidsCentella asiaticaneuroprotectiontau

Identifiers

PMID24448790
PMCPMC3973491
OpenAlexW1554984728

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.